Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors
Pietro Sollena(Università Cattolica del Sacro Cuore), Vasiliki Nikolaou(European Organisation for Research and Treatment of Cancer), F. Deilhes(Institut universitaire du cancer de Toulouse Oncopole), Gabriella Fabbrocini(Universitätsklinik für Chirurgie Wien), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Dimitra Voudouri(National and Kapodistrian University of Athens), Davide Fattore(University of Naples Federico II), Ηλίας Κοττέας(National and Kapodistrian University of Athens), Maria Carmela Annunziata(University of Naples Federico II), Nikolaos Soupos(Hospital Agioi Anargyroi), V. Sibaud(Institut Claudius Regaud), Zoé Apalla(Aristotle University of Thessaloniki), Ketty Peris(Università Cattolica del Sacro Cuore), Maria Concetta Romano(Carlo Forlanini Hospital), Armando Orlandi(Agostino Gemelli University Polyclinic), Alexandros Stratigos(National and Kapodistrian University of Athens)
Cited by 44
Related Papers
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
|European Journal of Cancer|2020|324
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
|European Journal of Cancer|2022|320
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
|European Journal of Cancer|2022|287
Understanding the Molecular Genetics of Basal Cell Carcinoma
|International Journal of Molecular Sciences|2017|243